Cross-posted from the Well being Companies Analysis web site.
Sponsored by: Division of Public Well being Sciences, College of Virginia College of Medication
Submission deadline for abstracts: Monday 17 July 2024
Well being Companies Analysis (HSR) and the Division of Public Well being Sciences, College of Virginia College of Medication are partnering to publish a Particular Situation on The Position of Well being Companies Analysis in Most cancers Prevention and Management. The particular challenge can be edited by Kevin Schulman, MD, Roger Anderson, PhD, Xin Hu, PhD, and Asal Pilehvari, PhD.
Paradigm shifts in most cancers screening comparable to mammography, colonoscopy, and Pap smears have been pivotal in detecting cancers at earlier and extra treatable phases. Remedies together with focused therapies, immunotherapies, and precision drugs have extended disease-free intervals, improved total survival, and enhanced high quality of life for survivors. Interventions within the supply and high quality of palliative care and hospice utilization have improved the end-of-life expertise. Well being companies analysis has contributed considerably to evaluating the effectiveness, accessibility, and implementation methods of those screening applications, therapies, and interventions, guiding their integration into medical observe.
Nonetheless, challenges persist in guaranteeing equitable entry to high-quality most cancers take care of all. Disparities in most cancers outcomes primarily based on elements together with socioeconomic standing, intercourse, gender identification, race, ethnicity, incapacity, comoribidities, care supply system, well being coverage, and geographical location stay a priority. Addressing these disparities and additional enhancing most cancers prevention and management methods requires a complete software of well being companies analysis.
Well being companies analysis can contribute to understanding how integrating revolutionary approaches of expertise comparable to synthetic intelligence (AI), predictive analytics, huge information analytics, and proof synthesis methodologies can enhance knowledgeable decision-making throughout the most cancers care continuum. Well being companies analysis also can inform coverage improvements that promote entry to care, and patient-centered care approaches. All current alternatives to additional improve most cancers prevention and management and enhance affected person outcomes.
This particular challenge will embrace empirical research that illuminate the applying of well being companies analysis all through the most cancers care continuum, from prevention and early detection to therapy, survivorship, and end-of-life care. Examples of matter areas of curiosity embrace however aren’t restricted to:
- Analysis of most cancers care high quality indicators, most cancers care utilization and financial outcomes, and/or organizational buildings or designs related to effectivity and effectiveness of most cancers care supply.
- Analysis of using cutting-edge applied sciences, together with AI and machine studying:
- to guage and/or quantify most cancers care high quality, utilization, and outcomes; or
- as a medical software to enhance customized therapy determination, most cancers care high quality and utilization in real-world-applications, comparable to danger stratification, sample recognition, or improved diagnostic accuracy.
- Technology of data-driven suggestions to handle the entry, price or high quality of most cancers take care of key stakeholders throughout the most cancers management continuum, from prevention to end-of-life care, together with however not restricted to insurance coverage corporations, skilled societies, well being care suppliers, governments, sufferers and caregivers.
HSR is issuing a name for abstracts to ask paper submissions for this particular challenge. The deadline for preliminary submission of abstracts is 17 July 2024. Abstracts could not exceed 300 phrases and should be formatted as indicated within the HSR Creator Directions (Part 2.4.2.2, key phrases not mandatory).
Abstracts can be evaluated by a multidisciplinary overview panel. Analysis standards embrace:
- High quality, rigor, and originality
- Relevance to the particular challenge theme
- Readability of writing and presentation.
Authors of abstracts that the majority intently match the factors can be invited in August to submit full manuscripts in November 2024.
Invited manuscripts should comply with the Creator Directions and endure the identical HSR peer overview course of as common challenge manuscripts. Nevertheless, as a result of strict timeline for publishing the particular challenge, the overview and revision course of will comply with an expedited timeline. Authors should be immediate in returning revisions. Invited articles can be printed on-line on acceptance. Some accepted articles may not be chosen for the particular challenge however can be printed in a daily challenge.
The anticipated publication date for the particular challenge is March 2026.
To submit an summary for consideration, please electronic mail it with the corresponding writer’s contact data to hsr@aha.org. Embrace “Particular Situation HSR in Most cancers” within the electronic mail topic line.
Key dates for authors
Submission deadline for abstracts: 17 July 2024
Full manuscript invitation: 12 August 2024
Full manuscript deadline: 15 November 2024
Particular challenge publication date: March 2026
Questions? Please electronic mail Kelly Teagle at hsr@aha.org.
